The #ANSEF2021 research grant is now entering the implementation stage. Our research project is being implemented in the framework of collaboration between L. A. Orbeli Institute of Physiology and Foldink Bioprinting Company.
This project, proposed by Foldink team, has been selected among 169 overall appplications and 56 finalists. The main topic of the research is the regeneration and 3D bioprinting of heart valves, particularly the aortic valves, with an aim to develop new treatment methods for patients with failure of this valve.
Valve heart disease (VHD) is one of the most common cardiovascular disorders, with a high prevalence, and presents a global healthcare challenge. The conventional treatment approaches for this disease include surgical repair/replacement of these valves. Innovative biomedical disciplines such as tissue engineering and 3D bioprinting, are developing solutions heart valve repair using bioengineered heart valve tissues, thus aiming to find safer and more available alternatives for transplantation.
Foldink team, in collaboration with the Laboratory of Immunology and Tissue Engineering (Orbeli Institute of Physiology), has already made certain progress in this research direction, and this grant will indeed facilitate our works in this direction.
Below, a news report by “Kentron” TV channel is presented, where Foldink’s CEO Emmanuel Ghandilyan presents this topic in more details.